Is prednisone (corticosteroid) effective in treating hand, foot, and mouth disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone Should NOT Be Used for Hand, Foot, and Mouth Disease

Prednisone and other corticosteroids are contraindicated in hand, foot, and mouth disease (HFMD) and may increase the risk of severe complications and death. 1, 2

Evidence Against Corticosteroid Use

The available evidence specifically addressing corticosteroids in HFMD demonstrates harm rather than benefit:

  • A case-control study found that glucocorticoid treatment was associated with a greater incidence of severe HFMD when used within 48 hours of onset or before diagnosis of critical disease. 2 This is the most direct evidence addressing your question and clearly demonstrates that corticosteroids worsen outcomes.

  • In a retrospective analysis of 637 severe HFMD cases, methylprednisolone administered at any stage made no significant difference on mortality (P > 0.05). 3 This study specifically evaluated corticosteroids in severe HFMD and found no benefit even in critically ill patients.

  • A cytokine profile study of HFMD patients treated with intravenous methylprednisolone showed no difference in expression levels of HFMD-associated biomarkers compared to untreated patients. 4 The steroid treatment failed to suppress the inflammatory response characteristic of HFMD, questioning any theoretical benefit.

Why Corticosteroids Are Harmful in HFMD

The mechanism of harm likely relates to:

  • HFMD is a viral illness caused by enteroviruses (particularly Enterovirus 71 and Coxsackievirus A16) that requires intact immune function for viral clearance. 1, 5 Corticosteroids suppress this necessary immune response.

  • Severe HFMD complications include neurological involvement (encephalitis, meningitis, acute flaccid paralysis) and cardiopulmonary complications. 1, 5 Immunosuppression during active viral replication may facilitate viral spread to the central nervous system.

Recommended Management Instead

The appropriate treatment for HFMD is supportive care only:

  • Oral analgesics (acetaminophen or NSAIDs) for pain and fever relief for a limited duration. 1

  • For oral lesions: Benzydamine hydrochloride oral rinse or spray every 3 hours, particularly before eating, to reduce inflammation and pain. 1

  • For skin lesions: Intensive moisturizing care with urea-containing creams, avoiding friction and heat exposure to affected areas. 1

  • Zinc oxide can be applied as a protective barrier for itchy skin lesions. 1

Critical Pitfall to Avoid

Do not prescribe corticosteroids for HFMD based on the presence of inflammation or fever. While the provided evidence includes guidelines discussing prednisone for various dermatologic conditions (hand and foot dermatoses like eczema and psoriasis 6), bullous pemphigoid 6, and other inflammatory conditions 6, these are entirely different disease entities from HFMD. The viral etiology and pathophysiology of HFMD make it fundamentally different from these inflammatory/autoimmune conditions where corticosteroids may be beneficial.

When to Escalate Care

For severe HFMD (CNS involvement, stage IV disease), the evidence-based interventions are:

  • Intravenous immunoglobulin (IVIG) applied in early stage IV significantly improved progression with an odds ratio of 0.24 (95% CI: 0.10-0.57). 3

  • Mechanical ventilation applied in early stage IV had an odds ratio of 0.01 (95% CI: 0.00-0.10) for mortality reduction. 3

Risk factors requiring close monitoring include: age <3 years, Enterovirus 71 infection, autonomic nervous system dysregulation, pulmonary edema/hemorrhage, CRP >40 mg/L, and cardiac troponin I >0.04 ng/ml. 3

References

Guideline

Diagnosis and Management of Hand, Foot, and Mouth Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Risk factors for critical disease and death from hand, foot and mouth disease.

The Pediatric infectious disease journal, 2014

Research

Current status of hand-foot-and-mouth disease.

Journal of biomedical science, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.